Matched-Pair Analysis Comparing the Outcomes of T Cell/Histiocyte-Rich Large B Cell Lymphoma and Diffuse Large B Cell Lymphoma in Patients Treated with Rituximab-CHOP

Publisher： Karger

E-ISSN： 1421-9662|131|3|156-161

ISSN： 0001-5792

Source： Acta Haematologica, Vol.131, Iss.3, 2013-10, pp. : 156-161

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Case of Pure Red Cell Aplasia Complicated with Diffuse Large B Cell Lymphoma, T-Cell-Rich/Histiocyte-Rich Variant: Effectiveness of Rituximab and Implications for a Common Immunopathogenic Role of B Lymphocytes

By  

Acta Haematologica, Vol. 113, Iss. 3, 2005-05 ,pp. : 194-197

Karger

Access to resources Recommend Favorite

Radiation for diffuse large B‐cell lymphoma in the rituximab era: Analysis of the National Comprehensive Cancer Network lymphoma outcomes project

By  

CANCER, Vol. 121, Iss. 7, 2015-04 ,pp. : 1032-1039

John Wiley & Sons Inc

Access to resources Recommend Favorite

Multiplex polymerase chain reaction‐based prognostic models in diffuse large B‐cell lymphoma patients treated with R‐CHOP

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 174, Iss. 6, 2016-09 ,pp. : 876-886

John Wiley & Sons Inc

Access to resources Recommend Favorite

Dose-Dense CHOP plus Rituximab (R-CHOP14) for the Treatment of Elderly Patients with High-Risk Diffuse Large B Cell Lymphoma: A Pilot Study

By  

Acta Haematologica, Vol. 115, Iss. 1-2, 2006-01 ,pp. : 22-27

Karger

Access to resources Recommend Favorite

Deliverability and efficacy of R‐CHOP chemotherapy in very elderly patients with diffuse large B‐cell lymphoma: an Australian retrospective analysis

By  

INTERNAL MEDICINE JOURNAL, Vol. 45, Iss. 11, 2015-11 ,pp. : 1147-1153

John Wiley & Sons Inc

Access to resources Recommend Favorite